NAD recommends Metabolic Research discontinues ad claims for Stemulite

NEW YORK The National Advertising Division of the Council of Better Business Bureaus on Wednesday recommended that Metabolic Research discontinue certain claims made for the company’s Stemulite dietary supplement.

Following its review, NAD recognized Metabolic Research for voluntarily discontinuing several claims — notably that Stemulite contributed to weight loss and increased strength.

NAD further found that there was insufficient evidence in the record to support remaining claims and testimonials regarding improvements or increases in sleep, muscle, endurance and wellness and energy, and recommended that they be discontinued.

The company, in its advertiser’s statement, said that it believes “the remaining claims, on a component by component basis, are supported by existing data.” However, the company noted, “We have retained counsel to further review our materials on an ongoing basis and have every intention on being compliant in all respects.”

NAD had initially instituted a review of Metabolic Research claims in 2009 and had forwarded claims to both the Food and Drug Administration and the Federal Trade Commission for review after Metabolic Rescearch declined to provide substantiation. NAD re-opened the review at the request of Metabolic Research, NAD reported.